Clinical Trial Update: Bioequivalence Study of Didanosine in Children Treated for HIV [Phase 2]

View source ↗

Summary

Phase 2 bioequivalence study of didanosine in HIV-infected children has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (Videx) (didanosine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: HIV Infections | Phase 2 | Status: SUSPENDED